L A Kalman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

L A Kalman

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposideJ D Hainsworth, J B Erland, L A Kalman, et al.

Cancer Treatment Reports|November 1, 1983

Phase I trial of PCNUL A Kalman, R J Gralla, E S Casper, et al.

Cancer|January 3, 2001

Carcinoma of unknown primary siteF A Greco, H A Burris, J B Erland, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensitiesJ D Hainsworth, J R Gray, S L Stroup, et al.

Cancer|February 1, 1985

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsM G Kris, R J Gralla, L B Tyson, et al.

Seminars in Oncology|March 4, 2000

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.

Cancer Treatment Reports|April 1, 1985

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessmentM G Kris, R J Gralla, L A Kalman, et al.

Cancer|March 15, 1997

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study GroupE B Rubenstein, R J Gralla, J D Hainsworth, et al.

Cancer|April 3, 1999

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposideJ D Hainsworth, J B Erland, L A Kalman, et al.

Cancer Treatment Reports|November 1, 1983

Phase I trial of PCNUL A Kalman, R J Gralla, E S Casper, et al.

Cancer|January 3, 2001

Carcinoma of unknown primary siteF A Greco, H A Burris, J B Erland, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensitiesJ D Hainsworth, J R Gray, S L Stroup, et al.

Cancer|February 1, 1985

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsM G Kris, R J Gralla, L B Tyson, et al.

Seminars in Oncology|March 4, 2000

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001

Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.

Cancer Treatment Reports|April 1, 1985

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessmentM G Kris, R J Gralla, L A Kalman, et al.

Cancer|March 15, 1997

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study GroupE B Rubenstein, R J Gralla, J D Hainsworth, et al.

Cancer|April 3, 1999

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.

Pageof 1